$DNA stock has now risen 18% today, according to our price data from Polygon. There has been approximately $11,333,048 of trading volume.
It has been the 558th most-searched ticker on Quiver Quantitative over the last day, out of 13,418 total tickers searched.
Here is what we see in our data on $DNA (you can track the company live on Quiver's $DNA stock page):
$DNA Insider Trading Activity
$DNA insiders have traded $DNA stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $DNA stock by insiders over the last 6 months:
- JASON R KELLY (See remarks) has made 0 purchases and 2 sales selling 206,782 shares for an estimated $1,374,493.
- RESHMA P. SHETTY (See remarks) has made 0 purchases and 3 sales selling 150,998 shares for an estimated $977,560.
- BARRY CANTON has made 0 purchases and 3 sales selling 150,998 shares for an estimated $977,560.
- STEVEN P. COEN (See remarks) has made 0 purchases and 6 sales selling 36,218 shares for an estimated $237,869.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$DNA Hedge Fund Activity
We have seen 81 institutional investors add shares of $DNA stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 843,605 shares (-26.1%) from their portfolio in Q4 2025, for an estimated $7,010,357
- MILLENNIUM MANAGEMENT LLC added 439,056 shares (+897.8%) to their portfolio in Q1 2026, for an estimated $2,691,413
- VANGUARD GROUP INC added 420,448 shares (+17.0%) to their portfolio in Q4 2025, for an estimated $3,493,922
- MORGAN STANLEY removed 306,487 shares (-40.0%) from their portfolio in Q1 2026, for an estimated $1,878,765
- TUDOR INVESTMENT CORP ET AL added 270,701 shares (+139.6%) to their portfolio in Q1 2026, for an estimated $1,659,397
- ALLIANZ ASSET MANAGEMENT GMBH added 250,728 shares (+55.7%) to their portfolio in Q1 2026, for an estimated $1,536,962
- LINGOTTO INVESTMENT MANAGEMENT LLP removed 250,282 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,534,228
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$DNA Revenue
$DNA had revenues of $19.5M in Q1 2026. This is a decrease of -59.7% from the same period in the prior year.
You can track DNA financials on Quiver Quantitative's DNA stock page.
You can access data on DNA stock through the Quiver Quantitative API.
$DNA Government Contracts
We have seen $27,031,790 of award payments to $DNA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM: $20,999,983
- DARPA ICE CONTROL FOR COLD ENVIRONMENTS (ICE): $1,559,859
- TEST SURGE AND DATA SHARING MULTIPLE AWARD IDIQ: $1,272,072
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$DNA Price Targets
Multiple analysts have issued price targets for $DNA recently. We have seen 2 analysts offer price targets for $DNA in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $5.0 on 03/12/2026
- Brendan Smith from TD Cowen set a target price of $12.0 on 01/08/2026
You can track data on $DNA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
